ENSYSCE BIOSCIENCES INC (ENSC) Fundamental Analysis & Valuation

NASDAQ:ENSC • US2936025046

Current stock price

0.5351 USD
+0.02 (+2.9%)
At close:
0.5071 USD
-0.03 (-5.23%)
After Hours:

This ENSC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ENSC Profitability Analysis

1.1 Basic Checks

  • ENSC had negative earnings in the past year.
  • In the past year ENSC has reported a negative cash flow from operations.
  • ENSC had negative earnings in each of the past 5 years.
  • In the past 5 years ENSC always reported negative operating cash flow.
ENSC Yearly Net Income VS EBIT VS OCF VS FCFENSC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M

1.2 Ratios

  • ENSC has a worse Return On Assets (-345.10%) than 92.64% of its industry peers.
  • The Return On Equity of ENSC (-911.79%) is worse than 80.81% of its industry peers.
Industry RankSector Rank
ROA -345.1%
ROE -911.79%
ROIC N/A
ROA(3y)-319.99%
ROA(5y)-221.77%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ENSC Yearly ROA, ROE, ROICENSC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 5K 10K 15K

1.3 Margins

  • ENSC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ENSC Yearly Profit, Operating, Gross MarginsENSC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ENSC Health Analysis

2.1 Basic Checks

  • There is no outstanding debt for ENSC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ENSC Yearly Shares OutstandingENSC Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
ENSC Yearly Total Debt VS Total AssetsENSC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • ENSC has an Altman-Z score of -68.64. This is a bad value and indicates that ENSC is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of ENSC (-68.64) is worse than 92.83% of its industry peers.
  • There is no outstanding debt for ENSC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -68.64
ROIC/WACCN/A
WACCN/A
ENSC Yearly LT Debt VS Equity VS FCFENSC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

  • ENSC has a Current Ratio of 1.27. This is a normal value and indicates that ENSC is financially healthy and should not expect problems in meeting its short term obligations.
  • ENSC has a Current ratio of 1.27. This is amonst the worse of the industry: ENSC underperforms 83.91% of its industry peers.
  • A Quick Ratio of 1.27 indicates that ENSC should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.27, ENSC is not doing good in the industry: 83.53% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27
ENSC Yearly Current Assets VS Current LiabilitesENSC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ENSC Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 68.51% over the past year.
EPS 1Y (TTM)68.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.14%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%44.33%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • The Revenue is expected to grow by 385.79% on average over the next years. This is a very strong growth
EPS Next Y14.44%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y385.79%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
ENSC Yearly Revenue VS EstimatesENSC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2027 20M 40M 60M 80M
ENSC Yearly EPS VS EstimatesENSC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -1K -2K -3K

More info and screens

Find the best growth stocksShow best growing peers

0

4. ENSC Valuation Analysis

4.1 Price/Earnings Ratio

  • ENSC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ENSC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ENSC Price Earnings VS Forward Price EarningsENSC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ENSC Per share dataENSC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ENSC Dividend Analysis

5.1 Amount

  • No dividends for ENSC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ENSC Fundamentals: All Metrics, Ratios and Statistics

ENSYSCE BIOSCIENCES INC

NASDAQ:ENSC (4/15/2026, 8:00:02 PM)

After market: 0.5071 -0.03 (-5.23%)

0.5351

+0.02 (+2.9%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-30
Earnings (Next)05-11
Inst Owners4.48%
Inst Owner Change0%
Ins Owners0.11%
Ins Owner Change0%
Market Cap4.97M
Revenue(TTM)N/A
Net Income(TTM)-10.97M
Analysts82.86
Price Target25.73 (4708.45%)
Short Float %2.12%
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.92%
Min EPS beat(2)-46.21%
Max EPS beat(2)34.36%
EPS beat(4)2
Avg EPS beat(4)9.75%
Min EPS beat(4)-46.21%
Max EPS beat(4)54.8%
EPS beat(8)5
Avg EPS beat(8)24.08%
EPS beat(12)9
Avg EPS beat(12)31.22%
EPS beat(16)11
Avg EPS beat(16)-101.82%
Revenue beat(2)1
Avg Revenue beat(2)37.92%
Min Revenue beat(2)-30.95%
Max Revenue beat(2)106.79%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)100%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.11
P/FCF N/A
P/OCF N/A
P/B 4.13
P/tB 4.13
EV/EBITDA N/A
EPS(TTM)-4.22
EYN/A
EPS(NY)-3.61
Fwd EYN/A
FCF(TTM)-0.77
FCFYN/A
OCF(TTM)-0.76
OCFYN/A
SpS0.48
BVpS0.13
TBVpS0.13
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -345.1%
ROE -911.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-319.99%
ROA(5y)-221.77%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.41
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z -68.64
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)68.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.14%
EPS Next Y14.44%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%44.33%
Revenue Next Year-100%
Revenue Next 2Y385.79%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-74.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-209.36%
EBIT Next 3Y51.15%
EBIT Next 5YN/A
FCF growth 1Y41.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y42.63%
OCF growth 3YN/A
OCF growth 5YN/A

ENSYSCE BIOSCIENCES INC / ENSC Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ENSYSCE BIOSCIENCES INC?

ChartMill assigns a fundamental rating of 2 / 10 to ENSC.


What is the valuation status for ENSC stock?

ChartMill assigns a valuation rating of 0 / 10 to ENSYSCE BIOSCIENCES INC (ENSC). This can be considered as Overvalued.


What is the profitability of ENSC stock?

ENSYSCE BIOSCIENCES INC (ENSC) has a profitability rating of 0 / 10.


What is the financial health of ENSYSCE BIOSCIENCES INC (ENSC) stock?

The financial health rating of ENSYSCE BIOSCIENCES INC (ENSC) is 5 / 10.


What is the earnings growth outlook for ENSYSCE BIOSCIENCES INC?

The Earnings per Share (EPS) of ENSYSCE BIOSCIENCES INC (ENSC) is expected to grow by 14.44% in the next year.